These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 219976)

  • 1. Epstein-Barr virus-related antibody patterns in ataxia-telangiectasia.
    Berkel AI; Henle W; Henle G; Klein G; Ersoy F; Sanal O
    Clin Exp Immunol; 1979 Feb; 35(2):196-201. PubMed ID: 219976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
    Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
    Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH; Wills A; Reece E; Fox Z
    Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
    Okano M
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
    Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
    Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis.
    Ferrell PB; Aitcheson CT; Pearson GR; Tan EM
    J Clin Invest; 1981 Mar; 67(3):681-7. PubMed ID: 6259207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV) antibodies in children with non-Hodgkin's lymphomas.
    Roubalová K; Weinreb M; Roubal J; Kodet R; Koutecký J; Vonka V
    Acta Virol; 1988 Jul; 32(4):339-48. PubMed ID: 2903639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
    Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
    Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serological signs of the Epstein-Barr virus (EBV) activity in the elderly.
    Ternák G; Szúcs G; Uj M
    Acta Microbiol Immunol Hung; 1997; 44(2):133-40. PubMed ID: 9330661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-related antibody pattern in uveitis.
    Sunakawa M; Okinami S
    Jpn J Ophthalmol; 1985; 29(4):423-8. PubMed ID: 3007826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma.
    Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T
    Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of Epstein-Barr virus DNA in tonsillar tissues.
    Brichácek B; Suchánková A; Hirsch I; Síbl O; Rezácova D; Závadová H; Vonka V
    Acta Virol; 1981 Nov; 25(6):361-70. PubMed ID: 6120637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of anti EBV antibodies in non-Hodgkin's lymphomams and angio-immunoblastic lymphadenopathies (author's transl)].
    Dumont J; Liabeuf A; Henle W; Ferchal F; Feingold N; Kourilsky FM
    Bull Cancer; 1979; 66(4):373-81. PubMed ID: 230873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus in pediatric patients after renal transplantation.
    Schwab M; Böswald M; Korn K; Ruder H
    Clin Nephrol; 2000 Feb; 53(2):132-9. PubMed ID: 10711415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1].
    Kwon KW
    Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to Epstein-Barr virus-induced early antigens in blood donors.
    Wohlrabe P; Färber I; Wutzler P; Uhlig R
    Acta Virol; 1989 Aug; 33(4):344-8. PubMed ID: 2574941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus antibodies in patients with laryngeal and hypopharyngeal cancer.
    Morshed K; Polz-Dacewicz M; Szymański M; Rajtar B; Ziaja-Sołtys M; Gołabek W
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):227-31. PubMed ID: 15323196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.